Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Lentivirus-mediated RNA interference of tripartite motif 68 inhibits the proliferation of colorectal cancer cell lines SW1116 and HCT116 in vitro.

Tan Z, Liu X, Yu E, Wang H, Tang L, Wang H, Fu C.

Oncol Lett. 2017 Apr;13(4):2649-2655. doi: 10.3892/ol.2017.5787. Epub 2017 Feb 28.

2.

Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma.

Jayachandran A, Dhungel B, Steel JC.

J Hematol Oncol. 2016 Aug 30;9(1):74. doi: 10.1186/s13045-016-0307-9. Review.

3.

BMI-1, a promising therapeutic target for human cancer.

Wang MC, Li CL, Cui J, Jiao M, Wu T, Jing LI, Nan KJ.

Oncol Lett. 2015 Aug;10(2):583-588. Epub 2015 Jun 11.

4.

Circulating cancer stem cells: the importance to select.

Yang MH, Imrali A, Heeschen C.

Chin J Cancer Res. 2015 Oct;27(5):437-49. doi: 10.3978/j.issn.1000-9604.2015.04.08. Review.

5.

Links between cancer stem cells and epithelial-mesenchymal transition.

Wang SS, Jiang J, Liang XH, Tang YL.

Onco Targets Ther. 2015 Oct 16;8:2973-80. doi: 10.2147/OTT.S91863. eCollection 2015. Review.

6.

Cancer microenvironment, inflammation and cancer stem cells: A hypothesis for a paradigm change and new targets in cancer control.

Blaylock RL.

Surg Neurol Int. 2015 May 29;6:92. doi: 10.4103/2152-7806.157890. eCollection 2015. Review.

7.

Lentivirus-mediated TPD52L2 depletion inhibits the proliferation of liver cancer cells in vitro.

Pan ZY, Yang Y, Pan H, Zhang J, Liu H, Yang Y, Huang G, Yin L, Huang J, Zhou WP.

Int J Clin Exp Med. 2015 Feb 15;8(2):2334-41. eCollection 2015.

8.

Differential cell adhesion of breast cancer stem cells on biomaterial substrate with nanotopographical cues.

Tan KK, Giam CS, Leow MY, Chan CW, Yim EK.

J Funct Biomater. 2015 Apr 21;6(2):241-58. doi: 10.3390/jfb6020241.

9.

Cancer stem cells in surgery.

D'Andrea V, Guarino S, Di Matteo FM, Maugeri SaccĂ  M, De Maria R.

G Chir. 2014 Nov-Dec;35(11-12):257-9.

10.
11.

Histone modifications: Targeting head and neck cancer stem cells.

Le JM, Squarize CH, Castilho RM.

World J Stem Cells. 2014 Nov 26;6(5):511-25. doi: 10.4252/wjsc.v6.i5.511. Review.

12.

Casein Kinase 2: a novel player in glioblastoma therapy and cancer stem cells.

Agarwal M, Nitta RT, Li G.

J Mol Genet Med. 2013 Dec 9;8(1). pii: 1000094.

13.

Internal ribosome entry site of bFGF is the target of thalidomide for IMiDs development in multiple myeloma.

Lien IC, Horng LY, Hsu PL, Wu CL, Sung HC, Wu RT.

Genes Cancer. 2014 Mar;5(3-4):127-41.

14.

Melanoma epigenetics: novel mechanisms, markers, and medicines.

Lee JJ, Murphy GF, Lian CG.

Lab Invest. 2014 Aug;94(8):822-38. doi: 10.1038/labinvest.2014.87. Epub 2014 Jun 30. Review.

15.

HMMR maintains the stemness and tumorigenicity of glioblastoma stem-like cells.

Tilghman J, Wu H, Sang Y, Shi X, Guerrero-Cazares H, Quinones-Hinojosa A, Eberhart CG, Laterra J, Ying M.

Cancer Res. 2014 Jun 1;74(11):3168-79. doi: 10.1158/0008-5472.CAN-13-2103. Epub 2014 Apr 7.

16.

Biomechanical profile of cancer stem-like/tumor-initiating cells derived from a progressive ovarian cancer model.

Babahosseini H, Ketene AN, Schmelz EM, Roberts PC, Agah M.

Nanomedicine. 2014 Jul;10(5):1013-9. doi: 10.1016/j.nano.2013.12.009. Epub 2014 Jan 6.

17.

Cellular reprogramming and hepatocellular carcinoma development.

Zheng YW, Nie YZ, Taniguchi H.

World J Gastroenterol. 2013 Dec 21;19(47):8850-60. doi: 10.3748/wjg.v19.i47.8850. Review.

18.

Stem cell-directed therapies in pancreatic cancer.

Kumar R, Dholakia A, Rasheed Z.

Curr Probl Cancer. 2013 Sep-Oct;37(5):280-6. doi: 10.1016/j.currproblcancer.2013.10.005. Epub 2013 Oct 8. Review. No abstract available.

19.

Systems and Network Pharmacology Approaches to Cancer Stem Cells Research and Therapy.

Muqbil I, Bao GW, El-Kharraj R, Shah M, Mohammad RM, Sarkar FH, Azmi AS.

J Stem Cell Res Ther. 2012 Dec 16;Suppl 7(5). pii: 10413.

20.

Fact or fiction--identifying the elusive multiple myeloma stem cell.

Kellner J, Liu B, Kang Y, Li Z.

J Hematol Oncol. 2013 Dec 7;6:91. doi: 10.1186/1756-8722-6-91. Review.

Supplemental Content

Support Center